Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Manhattan Associates Announces Date for Reporting Third Quarter 2026 Financial Results
-
OpenWorld Announces Term Sheet for Up to $130 Million IP-Backed Transaction with BeyondAI
-
TKO to Announce Third Quarter 2026 Results
-
Vanilla Becomes First Estate Planning Platform to Independently Validate Its Calculation Engine
-
Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets
-
Woodway Energy Infrastructure Appoints Russell Shriver as Chief Commercial Officer
-
General Mills Recognized on Forbes’ World's Best Employers 2026 List
-
NextDecade Announces Timing of Third Quarter 2026 Investor Call
-
Q.E.P. CO., INC. Declares Regular Quarterly Cash Dividend
-
Clean Harbors to Announce Third-Quarter 2026 Financial Results on October 28
-
Aline and eAdmit™ Partner to Deliver a Simpler, Faster Admissions Experience for Senior Living Operators
-
Fusemachines Launches fuse.ai to Showcase the Future of AI Twins in the Workplace
-
Mint Enters into OEM Supply and License Agreement with Ireland-based Centridex to Expand into Europe
-
Hard Rock Stadium Selects Clover Sport to Power Point-of-Sale Solutions
-
Alliance Entertainment Announces October 2026 Investor Conference Schedule
-
BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence
-
Cyllene Therapeutics Presents Interim Data from Phase 1b/2a Clinical Trial Showing EG110A Reduced Urinary Episodes in Patients with Spinal Cord Injury at the International Continence Society (ICS) Con
-
Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib
-
Dave’s Hot Chicken Gives Everyone a Free Slider on Dave’s Day; October 13 Marks the Fourth Annual Giveaway
-
Theialife Announces Positive Type C Meeting with FDA for ND10 in Progressive Myopia
-
RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial
-
OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company’s Real World Data Footprint into Korea and the Asia Pacific Region
-
AVAX One Announces Significant Balance Sheet Progress In Third Quarter 2026
-
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million
-
SEMA4D Blockade Reshapes the Tumor Immune Environment in Neoadjuvant Melanoma Study
-
DeFi Development Corp. to Participate in the 2026 Maxim Growth Summit
-
Beeline to Host Stakeholder Update Call on Q3 2026 Financial Results
-
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Töysän Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
-
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Kuortaneen Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
-
Ondas Secures Over $165 Million in New Orders Since Last Order Update
-
Apryse Expands Document SDKs to Reduce Custom Development Across AI, Editing and Capture Workflows
-
Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
-
Purina Pro Plan Veterinary Invests in Future Veterinarians with New Wellness Center at Utah State University
-
Windstar Cruises Unveils 2027 James Beard Foundation Chef Sailings
-
Diabetic Macular Edema Market is Projected to Grow by 2036 Owing to Rising Diabetes Burden and Advancements in Long-Acting Retinal Therapies | DelveInsight
-
KIDZ AI Joins AFCOM as Solution Provider Member to Advance High-Density AI Infrastructure and Enterprise GPU Cloud Commercialization
-
SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum A
-
SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Archi
-
Guelph psychotherapist preparing to ask Queen’s Park for OHIP coverage of psychotherapy
-
Express Wash Concepts Expands Michigan Presence with Davison Clean Express Auto Wash Grand Opening
-
Madison Street Capital Acts as Exclusive Advisor to IEM Electric, Inc. ("IEM") on its Sale to Norlee Group ("NLG")
-
Aesthetic Brokers Advises SDBotox on Strategic Partnership
-
PainTEQ Earns Eight 2026 Top Workplaces Culture Excellence Awards and Healthcare Industry Recognition
-
American Service Partners Launches National Home Services Platform, Acquiring Brands From Platform Partner Holdings and Exuma Capital
-
Prima Air Earns FAA Part 145 Certification, Expands MRO Capabilities
-
FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
-
Davis Polk Welcomes Prominent Media & Entertainment Partner Glen Mastroberte in Los Angeles
-
Duchenne Muscular Dystrophy Market is Projected to Grow at an 11% CAGR by 2036 Owing to the Advancement of Gene Therapies and Disease-Modifying Treatments | DelveInsight
-
Michael Aronovici: Why More Locations Is Not the Win Franchising Thinks It Is
-
Dravet Syndrome Market is Projected to Grow by 2036 Owing to Rising Diagnosis and Advancements in Gene-Targeted Therapies | DelveInsight
